TITLE

Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study

AUTHOR(S)
Qing-Lei Zeng; Bing Li; Xue-Xiu Zhang; Yan Chen; Yan-Ling Fu; Jun Lv; Yan-Min Liu; Zu-Jiang Yu
PUB. DATE
November 2016
SOURCE
Gut & Liver;Nov2016, Vol. 10 Issue 6, p955
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background/Aims: No clinical model exists to predict the occurrence of hepatocellular carcinoma in sustained virologic response-achieving (HCC after SVR) patients with chronic hepatitis C (CHC). Methods: We performed a case-control study using a clinical database to research the risk factors for HCC after SVR. A predictive model based on risk factors was established, and the area under the receiver operating characteristic curve (AUC) was calculated. Results: In the multivariate model, an initial diagnosis of compensated cirrhosis and post-SVR albumin reductions of 1 g/L were associated with 21.7-fold (95% CI, 4.2 to 112.3; p<0.001) and 1.3-fold (95% CI, 1.1 to 1.7; p=0.004) increases in the risk of HCC after SVR, respectively. A predictive model based on an initial diagnosis of compensated cirrhosis (yes, +1; no, 0) and post- SVR albumin ≤36.0 g/L (yes, +1; not, 0) predicted the occurrence of HCC after SVR with a cutoff value of >0, an AUC of 0.880, a sensitivity of 0.833, a specificity of 0.896, and a negative predictive value of 0.956. Conclusions: An initial diagnosis of compensated cirrhosis combined with a post-SVR albumin value of ≤36.0 g/L predicts the occurrence of HCC after SVR in patients with CHC.
ACCESSION #
119070876

 

Related Articles

  • Changes in serum complement components after 48 weeks of entecavir treatment in hepatitis B cirrhosis patients. ZHANG, Xuehua; LI, Zhongping // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;May2013, Vol. 29 Issue 5, p339 

    Objective To investigate the effects of entecavir treatment on serum complement components, C3 and C4, in patients with hepatitis B ciirhosis ad to determine their relation with treatment response. Methods Ninety - eight patients with hepatitis B ciirhosis who were treated with entecavir ( 10 mg...

  • Antiviral Treatment of HCV Carriers with Persistently Normal ALT Levels. Puoti, Claudio; Bellis, Lia; Galossi, Alessandra; Guarisco, Riccardo; Nicodemo, Sabino; Spilabotti, Lucia; Dell' Unto, Orlando // Mini Reviews in Medicinal Chemistry;Feb2008, Vol. 8 Issue 2, p150 

    Approximately 30% of patients with chronic HCV infection show persistently normal alanine aminotransferase levels (PNAL). The prevalence of HCV carriers with normal liver seems to be very low (less than 15-20%). Liver disease is usually minimal/mild and fibrosis is generally absent or minimal,...

  • Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin. Moon, Chansoo; Jung, Kyu; Kim, Do; Baatarkhuu, Oidov; Park, Jun; Kim, Beom; Kim, Seung; Ahn, Sang; Han, Kwang-Hyub // Digestive Diseases & Sciences;Feb2015, Vol. 60 Issue 2, p573 

    Background: To elucidate the benefits of successful antiviral therapy in chronic hepatitis C (CHC) patients Methods: A total of 463 CHC patients who underwent pegylated interferon alfa and ribavirin therapy were classified as sustained virological response (SVR) or non-SVR based on response to...

  • A Cure for the High Cost of Hepatitis C Virus Treatment. Etzion, Ohad; Ghany, Marc G. // Annals of Internal Medicine;5/5/2015, Vol. 162 Issue 9, Following p660 

    The authors discusses a study by B. P. Linas and others, published in the issue, regarding cost-effectiveness of the drug sofosbuvir-based regimens for treatment of hepatitis C virus (HCV) genotype 2 or 3 infection. They mentions the findings of the study which reveals that sofosbuvir-based...

  • Liver biopsy interpretation & the regression of hepatitis B virus related cirrhosis. Grizzi, Fabio; Desmet, Valeer J. // Indian Journal of Medical Research;Aug2014, Vol. 140 Issue 2, p160 

    The author discusses research studies on the prevalence of hepatitis B virus (HBV) related cirrhosis in India. Topics discussed include the interpretation of liver biopsy, importance of monitoring the genotypic resistance of HBV to antiviral agents, identification of serum alanine...

  • Rare complication of variceal embolization: a novel case. Oza, Veeral M.; Levine, Edward; Kirkpatrick III, Robert // Journal of Interventional Gastroenterology;7/ 1/2012, Vol. 3 Issue 3, p113 

    A letter to the editor is presented about the case of a 61-year-old female with a history of cirrhosis secondary to Hepatitis C who developed an embolization coil eroding thru a duodenal varix.

  • HEPATITIS C CIRRHOSIS--NOT NECESSARILY A TERMINAL DISEASE. Saeian, Kia; Reddy, K. Rajender; Johnson, David // American Journal of Gastroenterology;Aug1998, Vol. 93 Issue 8, p1386 

    Provides information on a study that evaluated the morbidity and survival of patients with compensated, histologically proven cirrhosis from hepatitis C virus infection. Methodology of the study; Results and discussion of the study.

  • Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Hofer, Harald; Bankl, Hans C.; Wrba, Friedrich; Steindl-Munda, Petra; Peck-Radosavljevic, Markus; Österreicher, Christoph; Mueller, Christian; Gangl, Alfred; Ferenci, Peter // American Journal of Gastroenterology;Nov2002, Vol. 97 Issue 11, p2880 

    OBJECTIVES:The aim of this study was to prospectively investigate the prevalence of hepatic steatosis in chronic hepatitis C patients with respect to viral genotype, hepatic iron concentration, total body iron, body mass index, and serum lipid parameters. Furthermore, the effect of hepatitis C...

  • Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Fattovich, G.; Olivari, N.; Pasino, M.; D'Onofrio, M; Martone, E.; Donato, F. // Gut;Jan2008, Vol. 57 Issue 1, p84 

    Objective: To assess risk factors for liver-related death, we re-evaluated, after a median follow-up of 25 years, a cohort of 70 Caucasian patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis (CH) at presentation. Methods: Follow-up studies included clinical and ultrasound...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics